Hostname: page-component-78c5997874-xbtfd Total loading time: 0 Render date: 2024-11-10T05:43:08.396Z Has data issue: false hasContentIssue false
  • English
  • Français

A presumably benign human ether-a-go-go-related gene mutation (R176W) with a malignant primary manifestation of long QT syndrome

Published online by Cambridge University Press:  09 November 2011

Birgit C. Donner ,
Christoph Marshall  and
Klaus G. Schmidt
Birgit C. Donner*
Affiliation:
Department of Paediatric Cardiology and Pneumology, University Childrens’ Hospital, Duesseldorf, Germany
Christoph Marshall
Affiliation:
Center for Human Genetics and Laboratory Medicine, Munich, Germany
Klaus G. Schmidt
Affiliation:
Department of Paediatric Cardiology and Pneumology, University Childrens’ Hospital, Duesseldorf, Germany
*
Correspondence to: Dr B. C. Donner, MD, PhD, Department of Paediatric Cardiology and Pneumology, University Children's Hospital, Moorenstrasse 5, 40225 Düsseldorf, Germany. Tel: +01149 (0) 211 811 7671; Fax: +01149 (0) 211 811 6287; E-mail: Birgit.Donner@med.uni-duesseldorf.de
Get access Rights & Permissions [Opens in a new window]

Abstract

A 12-year-old girl presented with a first prolonged syncope. She was successfully resuscitated by external defibrillation after recording torsade de pointes tachycardia. Repeated electrocardiograms and a 12-channel Holter monitoring showed an intermittent prolongation of the QT interval. Genetic analysis identified a heterozygous point mutation in the KCNH2 gene, which is thought to be associated with a rather mild clinical phenotype of the long QT syndrome.

Keywords

Torsade de pointesexternal defibrillationgenotype–phenotype correlation
Type
Brief Report
Information
Cardiology in the Young , Volume 22 , Issue 3 , June 2012 , pp. 360 - 363
Copyright
Copyright © Cambridge University Press 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Crotti, L, Celano, G, Dagradi, F, Schwartz, PJ. Congenital long QT syndrome. Orphanet J Rare Dis 2008; 3: 18–34.Google Scholar
2.Shimizu, W, Moss, AJ, Wilde, AAM, et al. Genotype–phenotype aspects of type-2 long-QT syndrome. J Am Coll Cardiol 2009; 54: 2052–2062.Google Scholar
3.Schwartz, PJ, Moss, AJ, Vincent, GM, Crampton, RS. Diagnostic criteria for the long QT syndrome: an update. Circulation 1993; 88: 782–784.CrossRefGoogle Scholar
4.Tester, DJ, Will, ML, Haglund, CM, Ackermann, MJ. Effect of clinical phenotype of yield of long QT syndrome genetic testing. J Am Coll Cardiol 2006; 47: 764–768.Google Scholar
5.Lupoglazoff, JM, Denjoy, I, Berthet, M, et al. Notched T waves on Holter recordings enhance detection of patients with LQTS2 (HERG) mutations. Circulation 2001; 103: 1095–1101.Google Scholar
6.Epstein, AE, DiMarco, JP, Ellenbogen, KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary. Circulation 2008; 117: 2820–2840.Google Scholar
7.Fodstad, H, Bendahhou, S, Rougier, JS, et al. Molecular characterization of two founder mutations causing long QT syndrome and identification of compound heterozygous patients. Ann Med 2006; 38: 294–304.Google Scholar
8.Marjamaa, A, Salomaa, V, Newton-Cheh, C, et al. High prevalence of four long QT syndrome founder mutations in the Finnish population. Ann Med 2009; 41: 234–240.Google Scholar
9.Ackerman, MJ, Splawski, I, Makielski, JC, et al. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Heart Rhythm 2004; 5: 600–607.Google Scholar
10.Kapplinger, JD, Tester, DJ, Salisbury, BA, et al. Spectrum and prevalence of mutations from the first 2500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm 2009; 9: 1297–1303.Google Scholar
11.Newton-Cheh, C, Guo, C-Y, Larson, MG, et al. Common genetic variation in KCNH2 is associated with QT interval duration: the Framingham heart study. Circulation 2007; 116: 1128–1136.Google Scholar
12.Migdalovich, D, Moss, AJ, Lopes, CM, et al. Mutation and gender specific risk in type-2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome. Heart Rhythm, 2011; 10: 1537–1543.Google Scholar